Biden names Dr. Ashish Jha new Covid response coordinator to succeed Jeff Zients

Biden names Dr. Ashish Jha new Covid response coordinator to succeed Jeff Zients


Dr. Ashish Jha is pictured in Providence, RI on Dec. 3, 2020.

Jonathan Wiggs | Boston Globe | Getty Images

President Joe Biden on Thursday named Dr. Ashish Jha as his new Covid-19 response coordinator to succeed Jeff Zients, who served in the role through the delta and omicron surges.

Jha leads Brown University’s School of Public Health and previously headed Harvard’s Global Health Institute. He is a well-known public commentator on how Americans should respond to health risks in the pandemic.

Jha, in a Twitter post, cautioned that the pandemic is not over and the U.S. needs to prepare for future variants and surges by keeping schools and workplaces safe.

New Covid infections in the U.S. have plunged more than 90% since the peak of an unprecedented omicron surge in January, according to data from Johns Hopkins University. Hospitalizations are down 89% from the omicron peak, according to the Centers for Disease Control and Prevention. However, infections are rising again in major European nations, such as the U.K. and Germany, and China is battling its worst outbreak since 2020.

Zients has led the White House Covid response team for 14 months and has held countless public briefings on the changing state of pandemic. Biden praised Zients’ work in a statement, noting that most adults have become fully vaccinated during his tenure. More than 75% of adults in the U.S. have received two doses of a vaccine, according to CDC data.

“The progress that he and his team have made is stunning and even more important consequential. Lives have been saved,” Biden said in a statement

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:



Source

Millions more Americans could access obesity drugs after Trump’s deals with Eli Lilly, Novo Nordisk
Health

Millions more Americans could access obesity drugs after Trump’s deals with Eli Lilly, Novo Nordisk

US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on Nov. 6, 2025. Andrew Caballero-Reynolds | AFP | Getty Images President Donald Trump on Thursday struck landmark deals with Eli Lilly and Novo Nordisk that could mark a turning point in how many people can access […]

Read More
Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows 
Health

Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows 

The Omada Health logo is displayed on a smartphone screen. Sopa Images | Lightrocket | Getty Images Virtual care company Omada Health on Thursday said it will start prescribing GLP-1s and other obesity drugs and helping patients manage those medications. Omada plans to expand the offerings under its weight management program as its membership grows […]

Read More
Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage
Health

Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage

U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White House in Washington, D.C., U.S. Nov. 6, 2025. Jonathan Ernst | Reuters President Donald Trump on Thursday announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of their obesity drugs, including upcoming […]

Read More